Related Experiment Video
Updated: May 7, 2026

07:38
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
[Nocturnal polyuria, treatment with desmopressin]
Ceska Gynekologie
|September 18, 2013
Summary
Desmopressin acetate is an effective treatment for nocturnal polyuria, reducing nighttime urination by decreasing urine production. Close monitoring is advised for patients over 65 due to potential hyponatremia risks.
Area of Science:
- Pharmacology
- Urology
Background:
- Nocturnal polyuria is a condition characterized by excessive nighttime urination.
- Treatment options include nonpharmacologic and pharmacologic approaches.
- Desmopressin acetate is a key pharmacologic treatment.
Purpose of the Study:
- To evaluate desmopressin acetate as a treatment for nocturnal polyuria.
- To outline its mechanism of action, dosage, and administration.
- To identify potential adverse effects and contraindications.
Main Methods:
- Desmopressin acetate, a synthetic vasopressin analogue, targets V2 receptors for antidiuretic effects.
- Oral administration one hour before bedtime.
- Dose titration from 60 µg to 240 µg based on clinical response.
- Fluid intake restriction before and after administration.
Main Results:
- Desmopressin reduces urine production and increases urine osmolality for 8-12 hours.
- Clinical studies showed a higher incidence of mild adverse events compared to placebo, including headache, nausea, and hyponatremia.
- Hyponatremia was more common in patients over 65 years of age.
Conclusions:
- Desmopressin acetate is a registered and effective treatment for nocturnal polyuria.
- Careful patient selection and monitoring, especially for those over 65, are crucial due to the risk of hyponatremia.
- Patients should be informed about the symptoms of hyponatremia.
Related Concept Videos
Diabetes Insipidus II: Pathophysiology
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
Diabetes Insipidus I: Introduction
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...